225
Participants
Start Date
June 23, 2017
Primary Completion Date
June 25, 2020
Study Completion Date
June 25, 2020
Cryoablation
Pulmonary vein isolation via ablation with cryoballoon catheter
Antiarrhythmic drug
Antiarrhythmic drug initiation
Geisinger Medical Center, Danville
Lehigh Valley Health, Allentown
Wellstar Research Institute, Marietta
BayCare Medical Group Cardiology, Tampa
Grandview Medical Center, Birmingham
Ohio State University, Columbus
Krannert Institute of Cardiology, Indianapolis
Spectrum Health Hospitals, Grand Rapids
Hoag Hospital Newport Beach, Newport Beach
Providence Saint Vincent Medical Center, Portland
Alaska Heart Institute, Anchorage
Iowa Heart Center, West Des Moines
Our Lady of the Lake Office of Research, Baton Rouge
University of Michigan Health System - University Hospital, Ann Arbor
Aurora Cardiovascular Services, Milwaukee
MedStar Washington Hospital Center, Washington D.C.
Tallahassee Research Institute Inc, Tallahassee
Southcoast Health System, New Bedford
HealthEast Saint Josephs Hospital, Saint Paul
Bryan Heart, Lincoln
The Valley Hospital, Ridgewood
Hackensack University Medical Center, Hackensack
Cleveland Clinic, Cleveland
Integris Baptist Medical Center, Inc., Oklahoma City
Medtronic Cardiac Ablation Solutions
INDUSTRY